Literature DB >> 24507568

Catechol-O-methyltransferase and genetic variation under hemizygosity.

Daniel Paul Eisenberg1, Karen F Berman2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24507568      PMCID： PMC4205935          DOI： 10.1016/j.biopsych.2013.12.011

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  9 in total

1.  [Not Available].

Authors:  J AXELROD
Journal:  Science       Date:  1957-08-30       Impact factor: 47.728

2.  Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.

Authors:  Doron Gothelf; Amanda J Law; Amos Frisch; Jingshan Chen; Omer Zarchi; Elena Michaelovsky; Renee Ren-Patterson; Barbara K Lipska; Miri Carmel; Bhaskar Kolachana; Abraham Weizman; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2013-08-28       Impact factor: 13.382

3.  Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure.

Authors:  A G Nackley; S A Shabalina; I E Tchivileva; K Satterfield; O Korchynskyi; S S Makarov; W Maixner; L Diatchenko
Journal:  Science       Date:  2006-12-22       Impact factor: 47.728

4.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.

Authors:  M F Egan; T E Goldberg; B S Kolachana; J H Callicott; C M Mazzanti; R E Straub; D Goldman; D R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

5.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.

Authors:  Venkata S Mattay; Terry E Goldberg; Francesco Fera; Ahmad R Hariri; Alessandro Tessitore; Michael F Egan; Bhaskar Kolachana; Joseph H Callicott; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

6.  Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain.

Authors:  Jingshan Chen; Barbara K Lipska; Nader Halim; Quang D Ma; Mitsuyuki Matsumoto; Samer Melhem; Bhaskar S Kolachana; Thomas M Hyde; Mary M Herman; Jose Apud; Michael F Egan; Joel E Kleinman; Daniel R Weinberger
Journal:  Am J Hum Genet       Date:  2004-09-27       Impact factor: 11.025

7.  Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis.

Authors:  D Mier; P Kirsch; A Meyer-Lindenberg
Journal:  Mol Psychiatry       Date:  2009-05-05       Impact factor: 15.992

8.  Hypothesis-driven candidate genes for schizophrenia compared to genome-wide association results.

Authors:  A L Collins; Y Kim; P Sklar; M C O'Donovan; P F Sullivan
Journal:  Psychol Med       Date:  2011-08-19       Impact factor: 7.723

9.  Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT).

Authors:  T Lencz; E Knowles; G Davies; S Guha; D C Liewald; J M Starr; S Djurovic; I Melle; K Sundet; A Christoforou; I Reinvang; S Mukherjee; Pamela DeRosse; A Lundervold; V M Steen; M John; T Espeseth; K Räikkönen; E Widen; A Palotie; J G Eriksson; I Giegling; B Konte; M Ikeda; P Roussos; S Giakoumaki; K E Burdick; A Payton; W Ollier; M Horan; G Donohoe; D Morris; A Corvin; M Gill; N Pendleton; N Iwata; A Darvasi; P Bitsios; D Rujescu; J Lahti; S L Hellard; M C Keller; O A Andreassen; I J Deary; D C Glahn; A K Malhotra
Journal:  Mol Psychiatry       Date:  2013-12-17       Impact factor: 15.992
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.